Back
Speaker illustration

Mr Maximilian Mueller

Deutsches Herzzentrum der Charite, Berlin (Germany)

Member of:

Heart Failure Association

Presentations

Bioactive adrenomedullin as a predictor of clinical outcomes in cardiac transthyretin amyloidosis

Event: Heart Failure 2025

Topic: Clinical

Session: Beating the odds: advances in cardiac amyloidosis treatment

Access
Like
Thumbnail

Prognostic staging system correctly identifies high risk groups in cardiac transthyretin amyloidosis treated with tafamidis

Event: ESC Congress 2024

Topic: Infiltrative Myocardial Disease

Session: Cardiac amyloidosis: how to stage and score

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novartis Explore sponsored resources
logo Novo Nordisk Explore sponsored resources